In DA neurons derived from PD patient cells, the activity of GCase and LRRK2 kinase was inversely proportional, with LRRK2 inhibition leading to increased GCase function in neurons from either LRRK2 or GBA1 mutation carriers, but also from control cells [57]. This evidence concerns the gene GBA1 and Parkinson disease.